Antibody-cytokine fusion breathes new life into glioblastoma therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37224224.
- Also identified by DOI 10.1126/scitranslmed.adh7674.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An antibody-cytokine fusion molecule combined with chemotherapy induces tumor regression in mice and patients with recurrent glioblastoma by boosting antitumor immunity (Look <i>et al.</i>).
Medical subject headings
- Cytokines
- Glioblastoma